POSTER SESSION V
Wednesday, March 5, 2008   —  9:30 AM - 12:00 Noon
Convention Center Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...


HEMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
168 Double Minute Chromosomes in Acute Myeloid Leukemias and Myelodysplastic Syndromes (1178)
Y Huh, SS Talwalkar, LV Abruzzo - UT MD Anderson Cancer Center, Houston, TX 		Add
169 CXCR4 Overexpression Is Associated with Poor Prognosis in AML Patients Independently of NPM1 Mutations (1193)
S Konoplev, H Lu, JB Rubin, HA Drabkin, HM Kantarjian, M Andreeff, M Konopleva - UT MD Anderson Cancer Center, Houston, TX; WU School of Medicine, St. Louis, MO; Medical University of South Carolina, Charleston, SC 		Add
170 The Clinical and Pathological Spectrum of Myeloid Disorders with the Isolated Interstitial Deletion of the Long Arm of Chromosome 5q (1135)
D Chen, JD Hoyer, A Tefferi, DP Steensma, RP Ketterling, CA Hanson - Mayo Clinic, Rochester, MN 		Add
171 Significance of NPM1 and FLT3 Mutations in Acute Myeloid Leukemia with Multilineage Dysplasia: Does NPM1 Identify a Lower Risk Group? (1283)
O Weinberg, J Merker, A Beck, M Seetharam, J Gotlib, J Zehnder, DA Arber - Stanford University, Stanford, CA 		Add
172 PTK-7: A Novel Marker for the Detection and Immunophenotyping of Acute Leukemias (1199)
Y Li, RC Braylan, SZ Al-Quran - University of Florida, Gainesville, FL 		Add
173 Multiparametric Flow Cytometric Analysis of Acute Promyelocytic Leukemia after Therapy (1200)
Y Li, I Bovio, RC Braylan, SZ Al-Quran - University of Florida, Gainesville, FL 		Add
174 Comparison of Serial Flow Cytometry Studies in Myelodysplasia Patients and Correlation with Hematologic, Bone Marrow, and Cytogenetic Status (1258)
D Stachurski - UMASS Memorial Med Ctr, Worcester, MA 		Add
175 Clinical Utility of Immunofluorescent Staining with PG-M3 Antibody in Rapid Diagnosis of Acute Promyelocytic Leukemia (1212)
I Mirza, T Paonessa, SF Lee - University of Alberta, Edmonton, Canada 		Add
176 A Specific Expression Pattern of CD56/CD16 of Myeloid Population by Flow Cytometry Study Can Predict the Presence of t(9;22) of Chronic Myelogenous Leukemia (1137)
S Chen, B Chin, AL Hii, KJ Bloom - Clarient Inc., Aliso Viejo, CA 		Add
177 A Short Flow Cytometry Panel of CD56 in Combination with Blast Count and/or CD117 Is Useful in Predicting MDS-Comparison Study of 6 Model Groups (1293)
L Zhang, J Savala, V Datta, J Mirocha, S Lee - USLabs, Irvine, CA; University of Tennessee, Memphis, TN; Cedars-Sinai Medical Center, LA, CA 		Add
178 The Significance of "Hematogones" in Mid Induction Chemotherapy Bone Marrow of Patients with Acute Leukemia (1250)
DW Sevilla, DA Oble, A Colovai, G Bhagat, B Alobeid - Columbia University, NY 		Add
179 Epidermal Growth Factor Receptor Gene Mutations, Amplification and Protein Expression in AML and MDS: A Study Using PCR, Immunohistochemistry and Flourescent In-Situ Hybridization (1157)
R El-Sabbagh Badr, C Riley, JR Lopategui - Cedars-Sinai Medical Center, Los Angeles, CA 		Add
180 Myelodysplastic Syndrome with Intermediate Risk Cytogenetics by International Prognostic Scoring System (1232)
O Pozdnyakova, PM Miron, SA Wang - UMASS Memorial Medical Center, Worcester, MA 		Add
181 Aurora Kinase A Expression in CD34+ Blasts from Acute Myeloid Leukemia and Myelodysplastic Syndromes (1287)
D Ye, G Garcia-Manero, M Fernandez, M Nguyen, LJ Medeiros, C Bueso-Ramos - University of Texas M.D. Anderson Cancer Center, Houston, TX 		Add
182 Myelodysplastic Syndrome with Erythroblasts [ge]50%: Clinicopathologic Features and Prognostic Grouping by Blast Enumeration (1270)
GL Tang, RP Hasserjian, F Truong, BA Woda, SA Wang - UMass Medical Center, Worcester, MA; Massachussetts General Hospital, Boston, MA 		Add
183 Acute Erythroleukemia (AML M6a) with Myeloblasts [lt]20% of Total Marrow Nucleated Cells: A Heterogeneous Group of Diseases? (1273)
F Truong, RP Hasserjian, G Tang, BA Woda, SA Wang - UMass Medical Center, Worcester, MA; Massachusetts General Hospital, Boston, MA 		Add
184 E-Cadherin Immunohistochemical Stain Is a Useful Specific Marker of Early Erythroid Elements in Bone Marrow Core Biopsies and Has Utility in MDS and Erythroleukemia (1220)
CG Morosan, RW Allan - University of Florida, Gainesville, FL 		Add
185 Acute Megakaryoblastic Leukemia: Immunophenotypic Differences in Patients with and without Down Syndrome (1228)
JM Peters, NJ Karanidikar, F Fuda, AA Arbini, HY Wang, W Chen - University of Texas Southwestern Medical Center, Dallas, TX 		Add
186 Differentiating CD4+/CD56+ Hematodermic Neoplasm from Acute Monoblastic Leukemia (1292)
IT Yu, D Rezania, JL Messina, LD Moscinski, HD Cualing - Moffitt Cancer Center/University of South Florida, Tampa, FL 		Add
187 Classification of Acute Leukemia by Immunohistochemistry on Bone Marrow Biopsy: A Study on 256 Cases ¤1183¥
S Jamal - Ziauddin University, Karachi, Pakistan 		Add
188 Myeloperoxidase Discordance between Cytochemical and Immunologic Methods in Acute Leukemias (1153)
TJ Dickason, CE Bueso-Ramos, JL Jorgensen - MD Anderson Cancer Center, Houston, TX 		Add
189 Bone Marrow Regulatory T-Cells Correlate with Outcome in Chronic Myelomonocytic Leukemia (1227)
Z Peerwani, R Tiu, B Serio, JP Maciejewski, ED Hsi - Cleveland Clinic, Cleveland, OH 		Add
190 JAK2 V617F+ and del(20q) Are Independent in Myeloproliferative Diseases (1281)
EX Wei, CE Bueso-Ramos, LJ Medeiros, P Lin - Saint Louis University, St. Louis, MO; University of Texas MD Anderson Cancer Center, Houston, TX 		Add
191 Testing for JAK2V617F Mutation across Specimen Types Yields Concordant Results (1214)
I Mirza, D Sekora, C Frantz - University of Alberta, Edmonton, Canada 		Add
192 JAK2 V617F Mutation Defines Two Subsets of Refractory Anemia with Ringed Sideroblasts and Marked Thrombocytosis with Distinctive Clinical and Morphologic Features (1256)
CP Soupir, J Vergilio, SA Wang, J Freeman, F Fend, RP Hasserjian - Massachusetts General Hospital, Boston, MA; Brigham & Women's Hospital, Boston, MA; UMass Medical Center, Worcester, MA; Baystate Medical Center, Springfield, MA; Technical University, Munich, Germany 		Add
193 pSTAT5 Expression during Disease Progression in Polycythemia Vera (1244)
AI Ruiz, S Aboudola, ED Hsi, CV Cotta - The Cleveland Clinic, Cleveland, OH 		Add
194 Immunohistochemical Analysis of Cell Cycle Proteins in Bone Marrow Lesions of Systemic Mastocytosis: Over Expression of p16INK4a May Be Associated with Indolent Clinical Behavior (1213)
I Mirza, X Jiang, MT Shabani-Rad, K Valentine, A Mansoor - University of Alberta, Edmonton, Canada; Univsersity of Calgary, Calgary, Canada 		Add
195 Occurrence of JAK2 V617F Mutation in Patients with Systemic Mastocytosis and Thrombocytosis (1209)
I Maric, W Fu, J Stoddard, TM Wilson, DD Metcalfe, J Robyn, P Noel - CC/NIH, Bethesda, MD; NIAID/NIH, Bethesda, MD 		Add
196 Bone Marrow Findings after KIT Tyrosine Kinase Inhibitor Midostaurine (PKC412) Therapy in Aggressive Systemic Mastocytosis (1164)
TI George, DA Arber, E Hsi, A Linder, A Ruddell, C Lanza, T Graubert, J Gotlib - Stanford, Stanford, CA; Cleveland Clinic, Cleveland, OH; Washington Univ, St. Louis, MO; Novartis Oncology, NJ, USA & Basel, Switzerland 		Add
197 Bone Marrow Biopsies in Elderly Patients 85 Years and Older (1205)
EM Manion, N Rosenthal - University of Iowa Carver College of Medicine, Iowa City, IA 		Add
198 Automated Grading of the Reticulin Stain of Bone Marrows Using AUTORETIC Algorithm (1165)
M Ghayouri, D Rezania, I Yu, L Moscinski, H Cualing - USF-Moffitt Cancer and Research Institute, Tampa, FL 		Add